Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV000788463 | SCV000927588 | uncertain significance | not provided | 2018-03-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001869207 | SCV002206093 | uncertain significance | Heterotopia, periventricular, X-linked dominant; Melnick-Needles syndrome; Oto-palato-digital syndrome, type II; Frontometaphyseal dysplasia | 2021-10-20 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt FLNA protein function. ClinVar contains an entry for this variant (Variation ID: 636591). This missense change has been observed in individual(s) with clinical features of FLNA-related conditions (PMID: 30986657). This variant is present in population databases (rs782740450, ExAC 0.002%). This sequence change replaces arginine with cysteine at codon 2041 of the FLNA protein (p.Arg2041Cys). The arginine residue is highly conserved and there is a large physicochemical difference between arginine and cysteine. |